NEW YORK (TheStreet) -- Medical stocks have held up well so far in the fourth quarter as the Health Care Select Sector SPDR Fund (XLV) traded up to a multi-year high of $41.40 on Oct. 17. Since then XLV has been moving sideways to down and on Wednesday morning opened with a downward gap below its 50-day simple moving average at $40.09.
Assuming that XLV ends the week below its five-week modified moving average at $39.96, the weekly chart profile will be downgraded to negative. Negative technicals are a symptom of what I call "QE fatigue."
At www.ValuEngine.com we show the medical sector 6.9% overvalued, and seven of the 10 components of XLV I am profiling here are overvalued by 3.4% to 32.7%, even after Wednesday's market decline.
Back on Aug. 8, I was premature with my story Book Profits on Health Care Stocks. I will update the profiles of the 10 stocks I covered that day including updated "buy and trade" strategies. Keep in mind that some health care stocks could get hurt by Obamacare, while pharmaceutical companies have their own stories of drugs under patent and drugs in the pipeline.
If you are trading the XLV ($39.53) here is the daily chart and my key levels. XLV is below its 21-day and 50-day simple moving averages at $40.50 and $40.09, signals that indicate risk to the 200-day at $37.84. My annual value levels are $36.71 and $34.12 with monthly and quarterly risky levels at $40.86 and $41.16.
Chart Courtesy of Thomson/Reuters
Reading the Table
OV/UN Valued: The stocks with a red number are undervalued by this percentage. Those with a black number are overvalued by that percentage according to ValuEngine.
VE Rating: A "1-Engine" rating is a Strong Sell, a "2-Engine" rating is a sell, a "3-Engine" rating is a hold, a "4-Engine" rating is a buy and a "5-Engine" rating is a strong buy.
Last 12-Month Return (%): Stocks with a red number declined by that percentage over the last 12 months. Stocks with a Black number increased by that percentage.
Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Dividend Stock Advisor
TRY IT FREENew! $49.95/yr
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Real Money
TRY IT FREE24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.
Product Features:
- Jim Cramer + 20 Wall Street pros
- Intraday commentary & news
- Real-time trading forum
- Actionable trade ideas
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV
